CJC-1295 with DAC is a GHRH-analogue peptide carrying a Drug Affinity Complex (DAC) modification that markedly extends its circulating half-life relative to Modified GRF 1-29. It is used in research comparing long- versus short-acting GHRH analogues in vitro and in preclinical models.
- Format: Lyophilised powder
Store lyophilised material at −20 °C, away from light and moisture. Every batch is independently analysed by Janoshik Analytical, with a batch-specific certificate of analysis (identity and purity) available on request.
Research use only. Not for human or veterinary consumption. Sold only to qualified researchers and institutions.
Research background: CJC-1295: What the Research Says






